Japan's Sosei buys Switzerland-based Idorsia Pharma's Japan, Korea units for $466m

Japanese biopharma company Sosei Group on Thursday bought Swiss-based Idorsia Pharmaceuticals’ operations in Japan and South Korea for about 65 billion yen ($466.1 million) in its largest acquisition to date.